SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-005935
Filing Date
2020-01-13
Accepted
2020-01-13 08:00:32
Documents
3
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d870449d8k.htm 8-K 18126
2 EX-99.1 d870449dex991.htm EX-99.1 22736
3 GRAPHIC g870449dsp05.jpg GRAPHIC 7723
  Complete submission text file 0001193125-20-005935.txt   53039
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 20522818
SIC: 2834 Pharmaceutical Preparations